I de to kliniske forsøg, hvor Twinrix Voksen blev administreret ved dag 0, 7 og 21, blev generaliserede og lokale symptomer set med samme frekvens som nævnt nedenfor.
In the two clinical trials in which Twinrix Adult was administered at 0, 7, 21 days, overall solicited general and local symptoms were reported with the same categories of frequency as defined below.